SEC Info - ENDRA Life Sciences Inc. - ‘8-K’ for 1/13/20

SEC Info℠

Home

My Interests

Help

Please Sign In

ENDRA Life Sciences Inc. – ‘8-K’ for 1/13/20

On: Wednesday, 1/15/20, at 10:12am ET · For: 1/13/20 · Accession #: 1654954-20-453 · File #: 1-37969

Previous ‘8-K’: ‘8-K’ on / for 12/27/19 · Next: ‘8-K’ on / for 3/10/20 · Latest: ‘8-K’ on / for 3/28/24 · 11 References:

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/15/20  ENDRA Life Sciences Inc.          8-K:1,7,9   1/13/20    3:76K                                    Blueprint/FA

Current Report — Form 8-K — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     20K 
 2: EX-10.1     Amendment to the Collaborative Research Agreement   HTML     21K 
 3: EX-99.1     Press Release                                       HTML     11K

Filing Submission 0001654954-20-000453 – SGML Text

Original SGML Text submitted by:	Blueprint/FA (as Filing Agent)

To view the SGML, please refresh
this page.

↑Top

ENDRA Life Sciences Inc. – ‘8-K’ for 1/13/20

On: Wednesday, 1/15/20, at 10:12am ET · For: 1/13/20 · Accession #: 1654954-20-453 · File #: 1-37969

Current Report — Form 8-K — Sect. 13 / 15(d) – SEA’34Filing Table of Contents

To view the SGML, please refresh this page.

Current Report — Form 8-K — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

To view the SGML, please refresh
this page.